全文获取类型
收费全文 | 417篇 |
免费 | 34篇 |
国内免费 | 26篇 |
出版年
2023年 | 13篇 |
2022年 | 6篇 |
2021年 | 16篇 |
2020年 | 13篇 |
2019年 | 17篇 |
2018年 | 17篇 |
2017年 | 14篇 |
2016年 | 17篇 |
2015年 | 21篇 |
2014年 | 37篇 |
2013年 | 33篇 |
2012年 | 25篇 |
2011年 | 22篇 |
2010年 | 8篇 |
2009年 | 19篇 |
2008年 | 12篇 |
2007年 | 19篇 |
2006年 | 26篇 |
2005年 | 15篇 |
2004年 | 16篇 |
2003年 | 15篇 |
2002年 | 13篇 |
2001年 | 6篇 |
2000年 | 5篇 |
1999年 | 9篇 |
1998年 | 3篇 |
1997年 | 8篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1994年 | 5篇 |
1993年 | 1篇 |
1992年 | 5篇 |
1991年 | 1篇 |
1990年 | 4篇 |
1989年 | 3篇 |
1988年 | 2篇 |
1987年 | 4篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1982年 | 6篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有477条查询结果,搜索用时 15 毫秒
61.
62.
《Cell cycle (Georgetown, Tex.)》2013,12(12):2221-2222
Comment on: Rankin EB, et al. Cell 2012; 149:63-74. 相似文献
63.
64.
Siliang Feng Shaohua Chang Lingdi Yan Huajin Dong Xiaoyu Xu Chenhong Wang Yuanjun Liang Keliang Liu 《Bioorganic & medicinal chemistry letters》2018,28(18):3038-3041
The approval of the erythropoietin (EPO) mimetic peptide drug peginesatide in 2012 was a breakthrough for the treatment of secondary anemia. However, due to severe allergic reactions, peginesatide was recalled a year later. In this study, 12 novel peptides were designed and synthesized by substituting specific amino acids of the monomeric peptide in peginesatide, with the aim of obtaining new EPO mimetic peptides with higher activities and lower side effects than the parent compound. Their cell proliferation activities were evaluated, and the structure-activity relationships were analyzed. Five compounds had equal cell proliferation activity to the control peptide. Among them, one compound showed a higher in vivo activity than the control peptide, with no obvious side effects. 相似文献
65.
66.
Fuquan Wu Ying Xu Min Xia Guanghui Ying Zhangfei Shou 《The Korean journal of parasitology》2016,54(3):315-317
Hookworm infections as well as other intestinal nematodiases are endemic in China. In this case, a 70-year-old male showed symptoms of chest tightness, shortness of breath, and both lower extremities edema. The diagnostic result was chronic renal insufficiency, chronic kidney disease (5th stage), and renal anemia at first. Then, he received treatment with traditional drugs. However, this treatment did not help to alleviate the symptoms of the patient significantly. The results of gastroendoscopy showed hookworms in the duodenum, also confirmed by pathology examination. Anemia was markedly ameliorated after eliminating the parasites. The results mentioned above suggested that ancylostomiasis was the leading causes of anemia in this patient, and the etiology of anemia in uremic patients should be systematically considered. Especially when anemia could not be cured by regular treatments, rare diseases should be investigated. 相似文献
67.
To investigate whether an erythropoietin (EPO) gene-based therapy could serve as an alternative to the repeated injection of rhEPO in treatment to renal anemia, the genetically modified myoblasts of rats, named Myo/ EPO, were implanted through intramuscular injection to model rats with renal anemia. The hemoglobin (Hb) and hematocrit (HCT) of the rats increased from (92. 5±3.0) g/L and 0.29 ±0.04 to the peak values of (103.8 ±5.0) g/L and 0. 32 ±0. 04 respectively 14 d after implantation, and sustained the pre-implantation level for 90 d. Otherwise, the control rats implanted with Myo/X, which carried the parent retroviral vector, gradually became severe in anemia. The PCR detection for hEPO cDNA in the rat muscle adjacent to injection sites indicated that the Myo/EPO cells survived for a long period in the muscle of rats. The results primarily demonstrate that myoblast gene transfer of EPO is effective for the treatment of rat renal anemia. 相似文献
68.
The role of human ribosomal proteins in the maturation of rRNA and ribosome production 总被引:2,自引:0,他引:2
Robledo S Idol RA Crimmins DL Ladenson JH Mason PJ Bessler M 《RNA (New York, N.Y.)》2008,14(9):1918-1929
Production of ribosomes is a fundamental process that occurs in all dividing cells. It is a complex process consisting of the coordinated synthesis and assembly of four ribosomal RNAs (rRNA) with about 80 ribosomal proteins (r-proteins) involving more than 150 nonribosomal proteins and other factors. Diamond Blackfan anemia (DBA) is an inherited red cell aplasia caused by mutations in one of several r-proteins. How defects in r-proteins, essential for proliferation in all cells, lead to a human disease with a specific defect in red cell development is unknown. Here, we investigated the role of r-proteins in ribosome biogenesis in order to find out whether those mutated in DBA have any similarities. We depleted HeLa cells using siRNA for several individual r-proteins of the small (RPS6, RPS7, RPS15, RPS16, RPS17, RPS19, RPS24, RPS25, RPS28) or large subunit (RPL5, RPL7, RPL11, RPL14, RPL26, RPL35a) and studied the effect on rRNA processing and ribosome production. Depleting r-proteins in one of the subunits caused, with a few exceptions, a decrease in all r-proteins of the same subunit and a decrease in the corresponding subunit, fully assembled ribosomes, and polysomes. R-protein depletion, with a few exceptions, led to the accumulation of specific rRNA precursors, highlighting their individual roles in rRNA processing. Depletion of r-proteins mutated in DBA always compromised ribosome biogenesis while affecting either subunit and disturbing rRNA processing at different levels, indicating that the rate of ribosome production rather than a specific step in ribosome biogenesis is critical in patients with DBA. 相似文献
69.
Clark RL Arima A Makori N Nakata Y Bernard F Gristwood W Harrell A White TE Wier PJ 《Birth defects research. Part B, Developmental and reproductive toxicology》2008,83(4):418-434
BACKGROUND: The developmental toxicity, toxicokinetics, and hematological effects of the antimalarial drug, artesunate, were previously studied in rats and rabbits and have now been studied in cynomolgus monkeys. METHODS: Groups of up to 15 pregnant females were dosed on Gestation Days (GD) 20–50 or for 3–7‐day intervals. RESULTS: At 30 mg/kg/day, 6 embryos died between GD30 and GD40. Histologic examination of 3 live embryos (GD26–GD36) revealed a marked reduction in embryonic erythroblasts and cardiomyopathy. At 12 mg/kg/day, 6 embryos died between GD30 and GD45. Four surviving fetuses examined on GD100 had no malformations, but long bone lengths were slightly decreased. At the developmental no‐adverse‐effect‐level (4 mg/kg/day), maternal plasma AUC was 3.68 ng.h/mL for artesunate and 6.93 ng.h/ml for its active metabolite, dihydroartemisinin (DHA). No developmental toxicity occurred with administration of 12 mg/kg/day for 3 or 7 days, GD29–31 or GD27–33 (maternal plasma AUC of 9.84 ng.h/mL artesunate and 16.4 ng.h/mL DHA). Exposures at embryotoxic doses were substantially lower than human therapeutic exposures. However, differences in monkey and human Vss for artesunate (0.5 L/kg vs. 0.18 L/kg) confound relying solely on AUC for assessing human risk. Decreases in reticulocyte count occur at therapeutic doses in humans. Changes to reticulocyte counts at embryotoxic doses in monkeys (≥12 mg/kg/day) were variable and generally minor. CONCLUSIONS: Artesunate was embryolethal at ≥12 mg/kg/day when dosed for at least 12 days at the beginning of organogenesis, but not when dosed for 3 or 7 days, indicating that developmental toxicity of artesunate is dependent upon duration of dosing in cynomologus monkeys. Birth Defects Res (Part B) 83:418–434, 2008. © 2008 Wiley‐Liss, Inc. 相似文献
70.
VP1 gene of chicken anemia virus in liver of infected chicken from Harbin was amplified by polymerase chain reaction and cloned into pUC18The recombinant vector was identified by restriction digestionThree clones were sequenced with sequencing kit ABI PRISM by TaKaRa CoLtdThe open reading frame of the VP1 gene is made up of 1,350bpIt encodes 449 amino acid residuesIt was found that there is an abundant Arg region from position 3 to 46Its isoelectric point is up to 107 because of its abundant basic amino acidsComparing this Harbin isolate with 26p4,Cux-1,82-2,Del-rose,A2,Connb,L-028,TR20,CIA-1,CAV15,2A9 showed there were 168 nucleoside differences which lead to 26 amino acid changes of the VP1The amino acid changes may influence the antigenic character of different VP1sIt was also found that there is a hyper-mutation region from amino acids position 139-157,its mutation frequency is up to 42% among these CAV's VP1s.It is necessary to research the function of this region 相似文献